Tag: T-cell response
AstraZeneca’s Covid-19 vaccine shows robust responses in Phase I and II...
Interim results from the ongoing Phase I and II COV001 trial, led by Oxford University, showed that AstraZeneca's AZD1222 was tolerated and generated robust...